Predictors of relapse rate in MS clinical trials

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Yearbook of Neurology and Neurosurgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0513-5117(08)79031-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors of relapse rate in MS clinical trials

  2005cited by this paper

• Multiple sclerosis relapse risk factors across treatment eras

  2025cites this paper
• Combining randomized and non‐randomized data to predict heterogeneous effects of competing treatments

  2023cites this paper
• Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosis

  2021cites this paper
• Systematic review of prediction models in relapsing remitting multiple sclerosis

  2020cites this paper
• Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China

  2019cites this paper
• A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis

  2017cites this paper
• Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review

  2015cites this paper
• Burden of risk variants correlates with phenotype of multiple sclerosis

  2015cites this paper
• Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β

  2014cites this paper
• Megadosis de metilprednisolona oral frente a intravenosa para el brote de esclerosis múltiple

  2013cites this paper
• Cladribine tablets for relapsing-remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study.

  2012cites this paper
• Placebo Cohorts in Phase-3 MS Treatment Trials – Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data

  2012cites this paper
• Associations among physical activity, perception of stress, and relapse occurrence in multiple sclerosis

  2011influential citation
• MWFmapping in multiple sclerosis using 3 D whole-brain multi-component relaxation MRI

  2011cites this paper
• Stress as a Risk Factor for Multiple Sclerosis Onset or Relapse: A Systematic Review

  2011cites this paper
• Aspects of multiple sclerosis that relate to experimental therapeutics

  2011cites this paper
• Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis

  2011cites this paper
• Medical chart validation of an algorithm for identifying multiple sclerosis relapse in healthcare claims

  2010cites this paper
• MRI as an outcome in multiple sclerosis clinical trials

  2009cites this paper
• Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.

  2009cites this paper
• Factors associated with the risk of secondary progression in multiple sclerosis

  2008cites this paper
• Incidence de la sclérose en plaques en Lorraine : fatigue et autres facteurs d'incapacité dans la cohorte LORSEP

  2006cites this paper
• Potential applications and limitations of proteomics in the study of neurological disease.

  2006cites this paper